News + Filings Transactions
|
Sofinnova Venture Partners X, L.P.
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 02/06/2023 | Vera Therapeutics, Inc. | | Purchase | Class A Common Stock | 285.7k | $7.00 | $2M | | 02/06/2023 |
| 08/11/2022 | CinCor Pharma, Inc. | | Purchase | Common Stock | 500k | $30.00 | $15M | By Sofinnova Venture Partners X, L.P. | 08/11/2022 |
| 02/10/2022 | Vera Therapeutics, Inc. | | Purchase | Class A Common Stock | 266.7k | $15.00 | $4M | | 02/10/2022 |
| 01/11/2022 | CinCor Pharma, Inc. | | Conversion | Common Stock | 5.2M | $0.00 | $0 | By Sofinnova Venture Partners X, L.P. | 01/11/2022 |
| 01/11/2022 | CinCor Pharma, Inc. | | Purchase | Common Stock | 325k | $16.00 | $5.2M | By Sofinnova Venture Partners X, L.P. | 01/11/2022 |
| 01/11/2022 | CinCor Pharma, Inc. | | Conversion | Series A Preferred Stock | 13.6M | $0.00 | $0 | By Sofinnova Venture Partners X, L.P. | 01/11/2022 |
| 01/11/2022 | CinCor Pharma, Inc. | | Conversion | Series B Preferred Stock | 4.3M | $0.00 | $0 | By Sofinnova Venture Partners X, L.P. | 01/11/2022 |
| 07/02/2021 | Aerovate Therapeutics, Inc. | AVTE | Conversion | Common Stock | 3.4M | $0.00 | $0 | | 07/02/2021 |
| 07/02/2021 | Aerovate Therapeutics, Inc. | AVTE | Purchase | Common Stock | 357.1k | $14.00 | $5M | | 07/02/2021 |
| 07/02/2021 | Aerovate Therapeutics, Inc. | AVTE | Conversion | Series A Preferred Stock | 10.6M | $0.00 | $0 | | 07/02/2021 |
| 05/18/2021 | Vera Therapeutics, Inc. | | Conversion | Series C Preferred Stock | 2.2M | $0.00 | $0 | | 05/18/2021 |
| 05/18/2021 | Vera Therapeutics, Inc. | | Purchase | Class A Common Stock | 727.3k | $11.00 | $8M | | 05/18/2021 |
| 05/18/2021 | Vera Therapeutics, Inc. | | Conversion | Class A Common Stock | 2.2M | $0.00 | $0 | | 05/18/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Conversion | Common Stock | 1.1M | $0.00 | $0 | | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Conversion | Common Stock | 1.2M | $0.00 | $0 | | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Purchase | Common Stock | 450k | $20.00 | $9M | | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Conversion | Series C-1 Preferred Stock | 1.1M | $0.00 | $0 | | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Conversion | Series C-2 Preferred Stock | 1.2M | $0.00 | $0 | | 02/09/2021 |
| 07/28/2020 | Inozyme Pharma, Inc. | INZY | Conversion | Common Stock | 1.6M | $0.00 | $0 | | 07/28/2020 |
| 07/28/2020 | Inozyme Pharma, Inc. | INZY | Purchase | Common Stock | 437.5k | $16.00 | $7M | | 07/28/2020 |
| 07/28/2020 | Inozyme Pharma, Inc. | INZY | Conversion | Series A-2 Convertible Preferred Stock | 11.9M | $0.00 | $0 | | 07/28/2020 |
| 06/30/2020 | Akouos, Inc. | AKUS | Conversion | Common Stock | 856.3k | $0.00 | $0 | | 06/30/2020 |
| 06/30/2020 | Akouos, Inc. | AKUS | Conversion | Common Stock | 600k | $0.00 | $0 | | 06/30/2020 |
| 06/30/2020 | Akouos, Inc. | AKUS | Purchase | Common Stock | 58.8k | $17.00 | $1000k | | 06/30/2020 |
| 06/30/2020 | Akouos, Inc. | AKUS | Conversion | Series A Preferred Stock | 18M | $0.00 | $0 | | 06/30/2020 |
| 06/30/2020 | Akouos, Inc. | AKUS | Conversion | Series B Preferred Stock | 12.6M | $0.00 | $0 | | 06/30/2020 |
|